ArticleAnnals of surgical oncology2021

Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes.

Lifen Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.